Otsu, Japan

Naoyuki Awazu


Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 43(Granted Patents)


Location History:

  • Shiga, JP (2001)
  • Kusatsu, JP (2001 - 2002)
  • Ritto, JP (2008)
  • Otsu, JP (2000 - 2011)

Company Filing History:


Years Active: 2000-2011

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Naoyuki Awazu: Innovator in Biotechnological Advancements

Introduction

Naoyuki Awazu is a prominent inventor based in Otsu, Japan. He has made significant contributions to the field of biotechnology, particularly through his innovative patents. With a total of 9 patents to his name, Awazu has established himself as a key figure in the development of novel biotechnological solutions.

Latest Patents

Among his latest patents, Awazu has developed a microorganism-derived psychrophilic endonuclease. This polypeptide, derived from a psychrophilic microorganism strain Ac10, exhibits high activity at low temperatures. It is capable of removing any nucleic acid present in a protein solution and can effectively reduce the viscosity of a protein extract. Additionally, he has patented a novel cyclic peptide that possesses antifungal activity, along with its pharmacologically acceptable salts and antifungal medicinal compositions.

Career Highlights

Throughout his career, Naoyuki Awazu has worked with notable companies such as Takara Shuzo Co., Inc. and Takara Bio Inc. His work in these organizations has allowed him to further his research and development efforts in biotechnology.

Collaborations

Awazu has collaborated with esteemed colleagues, including Ikunoshin Kato and Kazutoh Takesako. These partnerships have contributed to the advancement of his innovative projects and patents.

Conclusion

Naoyuki Awazu's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence advancements in biotechnological applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…